Document Detail

Sarcomas and the conservative management of uterine fibroids: a cause for concern?
MedLine Citation:
PMID:  11065039     Owner:  NLM     Status:  MEDLINE    
The introduction of conservative management options has further increased the choices available to clinicians treating women with symptomatic uterine fibroids. However, in the absence of a tissue diagnosis, the possibility of mismanaging an underlying uterine sarcoma is still present, placing these patients at potential risk of a delayed diagnosis of this serious pathology. Evidence suggests that 1 in 250-400 women presenting with what are thought to be symptomatic fibroids, will in fact have an underlying sarcoma, making this an important clinical issue. This paper therefore reviews the methods currently available for the assessment of women in whom conservative management of symptomatic fibroids is contemplated.
R W Dover; A J Ferrier; H W Torode
Related Documents :
21840329 - Dehydroepiandrosterone-sulphate replacement improves the human plasma fatty acid profil...
21436849 - The prevalence and analysis of risk factors for age-related macular degeneration: 18-ye...
23141029 - Gender-specific predictors of risky alcohol use among general hospital inpatients.
24054989 - Alcohol use and trauma exposure among male and female veterans before, during, and afte...
17344709 - Peripartum hysterectomy: 10-year experience in two manitoba tertiary centers.
17656199 - Prevalence of pelvic floor dysfunction in patients with interstitial cystitis.
17600259 - High school seniors' smoking initiation and progression 1 year after graduation.
11534059 - Cardiovascular risk factors of migrants in port moresby from the highlands and island v...
15578629 - Functional impairment as a risk factor for urinary incontinence among older americans.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  The Australian & New Zealand journal of obstetrics & gynaecology     Volume:  40     ISSN:  0004-8666     ISO Abbreviation:  Aust N Z J Obstet Gynaecol     Publication Date:  2000 Aug 
Date Detail:
Created Date:  2001-02-09     Completed Date:  2001-03-01     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0001027     Medline TA:  Aust N Z J Obstet Gynaecol     Country:  AUSTRALIA    
Other Details:
Languages:  eng     Pagination:  308-12     Citation Subset:  IM    
Royal North Shore Hospital, St Leonards, Sydney, New South Wales, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biopsy, Needle
Diagnosis, Differential
Gonadotropin-Releasing Hormone / administration & dosage
Leiomyoma / diagnosis*,  drug therapy,  pathology
Magnetic Resonance Imaging / methods
Middle Aged
Risk Assessment
Sarcoma / diagnosis*,  pathology,  therapy
Ultrasonography / methods
Uterine Neoplasms / diagnosis*,  drug therapy,  pathology
Reg. No./Substance:
33515-09-2/Gonadotropin-Releasing Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The management of pulsion enterocoele with the Zacharin abdominoperineal technique (and mesh sacroco...
Next Document:  Improved patient acceptability with a transdermal drug-in-adhesive oestradiol patch.